Evidence map›Paper›PMID 41890225›Full record

ArticleFrontiers in genetics2026

An auxiliary diagnosis model for the pathological classification of cervical cancer based on radiomics biomarkers.

Mei Wang, Yu Cao, Mengchen Zhu, Peilin Zhao, Qin Zhou, Hongxiang Lan, Jizhao Liu, Junqiang Lei

Abstract read
In one paragraph

Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mei WangThe First Clinical Medical College, Lanzhou University, Lanzhou, China.
Yu CaoThe First Clinical Medical College, Lanzhou University, Lanzhou, China.
Mengchen ZhuThe First Clinical Medical College, Lanzhou University, Lanzhou, China.
Peilin ZhaoThe Second Clinical Medical College, Lanzhou University, Lanzhou, China.
Qin ZhouSchool of Electronic and Information Engineering, Lanzhou Jiaotong University, Lanzhou, China.
Hongxiang LanSchool of Information Science and Engineering, Lanzhou University, Lanzhou, China.
Jizhao LiuSchool of Information Science and Engineering, Lanzhou University, Lanzhou, China.
Junqiang LeiThe First Clinical Medical College, Lanzhou University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cervical cancer remains a major global health burden, and accurate pathological classification is essential for personalized treatment planning. However, conventional radiomics studies often rely on manual lesion delineation and are limited in extracting meaningful imaging biomarkers from heterogeneous cervical cancer lesions. Methods: We proposed a convolutional recurrent feature extraction (CRFE)-based automatic segmentation framework for cervical cancer MRI images and developed histogram-based imaging features reflecting lesion pixel concentration trends. These features were integrated with conventional radiomics and clinical features. Feature engineering and machine learning classifiers, including random forest (RF), XGBoost, support vector machine, and logistic regression, were evaluated to construct an auxiliary diagnostic model for pathological classification. The dataset included 114 patients with cervical cancer who underwent MRI examinations. Results: The CRFE segmentation model achieved an Intersection over Union (IoU) of 0.9443, a Dice coefficient of 0.5980, and an F1-score of 0.7085. Feature selection retained 30 key imaging biomarkers, including the median of the histogram, GLSZM large-area low gray-level emphasis (LoG, Discussion: The proposed deep learning-radiomics framework enables accurate lesion segmentation and effective pathological classification of cervical cancer. This auxiliary diagnostic model may reduce unnecessary invasive procedures and improve early screening and clinical decision-making.

Indexed as

biomarkerscervical cancermedical image segmentationpathological classificationradiomics

Identifiers

PMID41890225
PMCPMC13012859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.